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Portuguese Pulmonology
footprint in Europe: From
abstracts to papers and grants
To  the  Editor,
Now  that  the  Portuguese  Journal  of  Pulmonology  ha
reached  the  highest  impact  factor  of  the  national  medic
journals,1 it  is  worth  analyzing  other  indicators  of  nation
respiratory  research.
To  be  widely  recognized  as  a  mature  medical  society  an
specialty,  Pulmonology  needs  to  leave  a  distinct  intern
tional  footprint.
What  image  does  the  Portuguese  Pulmonology  present  t
the  international  arena?
Participation in the European Respiratory
Society (ERS) Congress
Portuguese  participation  in  the  ERS  has  been  increasing  in
recent  years  (Fig.  1)  reaching  in  2015,  2.1%  of  accepted
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abstracts.  However  this  number  is  below  the  Europea
representation  of  other  Portuguese  societies;  it  is  even  lowe
than  that  of  Greece  in  2006  (Greece  in  2006,  13.7  abstrac
per  million  inhabitants  versus  Portugal  in  2015,  8.8  abstrac
per  million  inhabitants).2
During  2015,  the  ERS  meeting  in  Amsterdam  had  23.29
participants,  317  of  which  were  Portuguese  (1.4%).  Out  o
the  5088  abstracts  submitted,  136  were  sent  from  Portug
(2.7%);  Total  acceptance  rate  was  79%  while  the  acceptanc
rate  of  Portuguese  abstracts  was  63%  very  close  to  Ind
(61%)  and  Egypt  (63%)  (Fig.  2).
Bibliometry of respiratory medicine research
According  to  the  report  from  General  Directorate  for  educ
tion  and  health  statistics3 (Direc¸ão Geral  de  Estatísticas  d
Educac¸ão  e  Ciência)  for  Pulmonology,  in  2012,  the  number  o
publications  indexed  in  Web  of  Science  was  5.88  per  million
inhabitants,  only  better  than  Luxembourg  and  a long  way
from  Holland  the  leader  in  Europe  with  22.95  publications
per  million  inhabitants.  Since  2007,  indexed  publications  on
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the  Respiratory  systems  increased  to  a  peak  in  2009  with
around  8  per  million  inhabitants,  declining  in  2012  to  around
6  per  million  inhabitants.  This  is  far  below  the  indexed  pub-
lications  of  cardiac  and  cardiovascular  system  in  2012  with
more  than  16  per  million  inhabitants.  Moreover  analyzing  the
impact  per  publication  during  2008--2012  Portuguese  Pul-
monology  is  at  the  bottom  of  the  list,  compared  with  other
medical  disciplines,  with  Critical  Care,  Allergy  and  Anesthe-
siology  leading  the  group.
Participation of Portuguese centres on EU
funded projects
The  Seventh  Framework  Programme  for  Research  and  Tech-
nological  Development  showed  a  signiﬁcant  number  of
funded  projects  in  the  area  of  chronic  lung  disorders,  tuber-
culosis  and  cancer  with  an  amount  of  over  D  350  Million.4
Spain  got  D  27  Million,  Holland  D  30  Million,  Italy  D  27  Mil-
lion,  Greece  D  12  Million,  while  Portugal  only  managed  D  3
Million  (including  2  projects  in  COPD  and  2  projects  in
cancer).  Three  participants  came  from  academia  (HOME-
CARE  project  including  the  University  of  Aveiro,  WELCOME
project  including  the  University  of  Coimbra  and  IL7sigNETure
coordinated  by  the  IMM-Instituto  de  Medicina  Molecular)  and
one  from  industry  (LUNGCARD  project  coordinated  by  STAB
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ure  2  Abstracts  acceptance  rate  (%)  by  country  at  ERS
ngress  2015.
4. A,  Investigac¸ão  e  servic¸os em  ciências  biológicas).
So,  unfortunately,  Portuguese  Pulmonology  footprint  in
rope  is  much  smaller  what  should  be  expected.
What  should  we  aim  for  in  the  future?  To  keep  Por-
uese  Pulmonology  hidden  from  Europe,  like  a  stone  raft
 .  .navigate  other  seas,  trusting  in  the  talent  and  creativity
the  boldest?
We  need  to  support  the  new  generations  of  pulmonolo-
ts  to  reach  excellence  in  research  by  reinforcing  local  and
ernational  networks.  A  strong  respiratory  research  organi-
tion  is  highly  desirable.  Collaboration  between,  academia,
nicians,  scientiﬁc  societies  and  industry  is  strongly  recom-
nded.  Tightly  monitoring  the  progress  of  this  endeavour
mandatory!  Only  If  we  succeed  in  this  may  we  hope  for  a
tter  healthcare  in  the  future!
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Asthma prevalence in
Portuguese preschool children:
More scientiﬁc evidence.  . .
Dear  Editor,
We  read  with  interest  the  research  letter  ‘‘Asthma  preva-
lence  in  Portuguese  preschool  children:  The  latest  scientiﬁc
evidence’’,  published  by  Branco  et  al.1 The  authors  intended
to  review  the  major  ﬁndings  of  published  papers  on  child-
hood  asthma  prevalence  in  preschool-aged  children  in  our
country.  We  agree  with  the  authors  that  it  is  important
to  have  nationwide-based  surveys,  so  we  would  like  to
brieﬂy  cite  two  large  surveys  that  were  published  by  our
group,  and  that  can  contribute  to  the  knowledge  about
asthma  and  recurrent  wheezing  in  the  same  age  group
(Table  1).2,3
The  ﬁrst  survey  was  a  cross-sectional,  questionnaire-
based  (ISAAC-adapted)  descriptive  study  of  children  aged
between  3  and  5  years  living  in  mainland  Portugal
(ARPAkids);  a  representative  sample  of  5003  children  was
included  in  the  analysis.2
The  prevalence  of  ‘‘wheezing  in  the  last  12  months’’  (cur-
rent  wheezing  --  CW)  was  24.5%  [95%  conﬁdence  interval
(CI)  23.3--25.7];  most  of  these  children  (61.4%)  had  had  1--3
wheezing  episodes  in  the  previous  year,  and  7.5%  reported
>12  episodes.  The  prevalence  of  CW  was  signiﬁcantly  higher
in  children  with  a  family  history  of  allergic  disease;  those  liv-
ing  in  rural  regions  had  a  signiﬁcantly  lower  wheezing  preva-
lence.  No  statistically  signiﬁcant  differences  were  found  for
gender,  age,  birth  weight,  or  exposure  to  tobacco  smoke
at  home.  The  prevalence  of  ‘‘physician  diagnosed  asthma’’
(PDA)  in  children  with  CW  was  16.7%  [95%  CI  14.6--18.8]  --  vs.
4.6%  [95%  CI  4.0--5.2]  in  the  general  population;  it  was  high
est  (73.0%)  in  those  with  >12  wheezing  episodes.
CW  was  strongly  associated  with  rhinitis  in  this  ag
group,  especially  with  moderate  --  severe  persistent  disease
children  with  both  wheezing  and  rhinitis  had  more  whee
ing  episodes  and  needed  treatment  more  frequently.  Th
number  of  wheezing  episodes  signiﬁcantly  increased  wit
increasing  rhinitis  severity/persistency.2,4
The  second  survey  included  the  paediatric-speciﬁc  dat
(n  = 716;  21.4%  younger  than  6  years  of  age)  from  
cross-sectional,  population-based,  all-age,  nationwide  tele
phone  interview  study  (INAsma),  the  ﬁrst  population-base
epidemiological  study  aiming  to  estimate  asthma  prev
lence  in  Portugal  covering  all  ages.3 The  methodolog
of  this  study  has  been  previously  described5;  a  GA2LEN
adapted  questionnaire  was  used.  ‘‘Current  asthma’’  (CA
was  deﬁned  as  a  positive  answer  to  ‘‘has  the  child  eve
had  asthma?’’,  plus  at  least  one  of  4:  wheezing,  wakin
with  breathlessness  or  having  had  an  asthma  attack  in  th
previous  12  months,  or  currently  taking  asthma  medic
tion.
In children  aged  <6  years,  the  prevalence  of  CW  and  C
was  31.0%  (95%  CI  24.4--38.5)  and  6.5%  (95%  CI  3.5--11.6
respectively.  No  statistically  signiﬁcant  differences  wer
found  in  the  prevalence  of  CA  according  to  region  or  othe
socio-demographic  variables,  but  a  higher  risk  for  CA  wa
found  in  children  with  rhinitis  and  eczema.3
In  conclusion,  asthma-like  symptoms  were  present  
one-third  to  one-fourth  of  Portuguese  preschool  children
the  prevalence  of  PDA  was  4.6%  (ARPAkids)  and  of  CA  wa
6.5%  (INAsma).  Asthma  prevalence  can  vary  signiﬁcant
according  to  different  study  methodologies,  namely  di
ease  deﬁnition,  and  objective  markers  of  disease  must  b
included  in  future  surveys.
